Latest filing published 23 Jun 2026 for PROTAGONIST THERAPEUTICS, INC., €910k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
William Waddill: trading record in brief
William Waddill is a declared insider of Protagonist Therapeutics, Inc, with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated from 10 June 2026 to 23 June 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 23 June 2026 came the latest disclosure, a transaction for €910k in Protagonist Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to William Waddill
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,000 shares@ US$115.03100.0% of flowCommonSEC144:0001950047-26-006422
- 9,000 shares@ US$105.87CommonSEC144:0001950047-26-005894
2 of 2 declarations
